Order Article Reprints

Zhang Y, Vagiannis D, Budagaga Y, Sabet Z, Hanke I, Rozkoš T, Hofman J. Encorafenib Acts as a Dual-Activity Chemosensitizer through Its Inhibitory Effect on ABCC1 Transporter In Vitro and Ex Vivo. Pharmaceutics. 2022; 14(12):2595. https://doi.org/10.3390/pharmaceutics14122595

Zhang, Yu, Dimitrios Vagiannis, Youssif Budagaga, Ziba Sabet, Ivo Hanke, Tomáš Rozkoš, and Jakub Hofman. 2022. "Encorafenib Acts as a Dual-Activity Chemosensitizer through Its Inhibitory Effect on ABCC1 Transporter In Vitro and Ex Vivo" Pharmaceutics 14, no. 12: 2595. https://doi.org/10.3390/pharmaceutics14122595

Zhang, Y., Vagiannis, D., Budagaga, Y., Sabet, Z., Hanke, I., Rozkoš, T., & Hofman, J. (2022). Encorafenib Acts as a Dual-Activity Chemosensitizer through Its Inhibitory Effect on ABCC1 Transporter In Vitro and Ex Vivo. Pharmaceutics, 14(12), 2595. https://doi.org/10.3390/pharmaceutics14122595